T1	AdverseReaction 580 605	Cytokine Release Syndrome
T2	AdverseReaction 607 610	CRS
T3	Severity 626 642	life-threatening
T4	AdverseReaction 646 651	fatal
T5	Factor 619 622	may
T6	AdverseReaction 699 717	Infusion reactions
T7	AdverseReaction 899 906	pyrexia
T8	AdverseReaction 908 916	headache
T9	AdverseReaction 918 924	nausea
T10	AdverseReaction 926 934	asthenia
T11	AdverseReaction 936 947	hypotension
T12	AdverseReaction 949 983	increased alanine aminotransferase
T13	AdverseReaction 985 1021	increased aspartate aminotransferase
T14	AdverseReaction 1027 1052	increased total bilirubin
T15	AdverseReaction 1133 1138	fatal
T16	AdverseReaction 1139 1142	CRS
T17	Severity 1113 1129	Life-threatening
T18	AdverseReaction 1216 1254	disseminated intravascular coagulation
T19	AdverseReaction 1256 1259	DIC
T20	AdverseReaction 1262 1285	capillary leak syndrome
T21	AdverseReaction 1287 1290	CLS
T22	AdverseReaction 1297 1331	hemophagocytic lymphohistiocytosis
T23	AdverseReaction 1332 1362	macrophage activation syndrome
T24	AdverseReaction 1364 1367	HLH
T25	AdverseReaction 1368 1371	MAS
T26	AdverseReaction 1410 1413	CRS
T27	AdverseReaction 1736 1759	neurological toxicities
T28	AdverseReaction 1929 1952	neurological toxicities
T29	Severity 1893 1899	severe
T30	Severity 1901 1917	life-threatening
T31	Severity 1874 1881	Grade 3
T32	AdverseReaction 1922 1927	fatal
T33	AdverseReaction 2056 2070	encephalopathy
T34	AdverseReaction 2072 2083	convulsions
T35	AdverseReaction 2085 2101	speech disorders
T36	AdverseReaction 2103 2132	disturbances in consciousness
T37	AdverseReaction 2134 2143	confusion
T38	AdverseReaction 2148 2162	disorientation
T40	AdverseReaction 2168 2180;2193 2202	coordination disorders
T41	AdverseReaction 2185 2202	balance disorders
T39	AdverseReaction 2603 2613	infections
T42	Severity 2595 2602	serious
T43	AdverseReaction 2622 2628	sepsis
T44	AdverseReaction 2630 2639	pneumonia
T45	AdverseReaction 2641 2651	bacteremia
T46	AdverseReaction 2795 2800	fatal
T47	AdverseReaction 2653 2677	opportunistic infections
T48	AdverseReaction 2683 2707	catheter-site infections
T49	Severity 2775 2791	life-threatening
T50	AdverseReaction 3038 3058	Tumor lysis syndrome
T51	AdverseReaction 3060 3063	TLS
T52	Severity 3079 3095	life-threatening
T53	AdverseReaction 3099 3104	fatal
T54	Factor 3072 3075	may
T55	AdverseReaction 3572 3583	Neutropenia
T56	AdverseReaction 3588 3607	febrile neutropenia
T57	Severity 3619 3635	life-threatening
T58	AdverseReaction 3979 3996	neurologic events
T59	Factor 3965 3974	potential
T60	AdverseReaction 4008 4016	seizures
T61	AdverseReaction 4062 4083	loss of consciousness
T62	Factor 4053 4057	risk
T63	AdverseReaction 4415 4442	elevations in liver enzymes
T64	AdverseReaction 4514 4517	CRS
T65	AdverseReaction 4690 4717	elevations in liver enzymes
T66	Severity 4671 4678	Grade 3
T67	AdverseReaction 5313 5332	leukoencephalopathy
T68	AdverseReaction 53 63	Infections
T69	AdverseReaction 144 171	Effects on Ability to Drive
T70	AdverseReaction 144 165;176 188	Effects on Ability to Use Machines
T71	Severity 4405 4414	transient
T73	AdverseReaction 886 889	CRS
T72	AdverseReaction 4782 4785	CRS
T74	Negation 4759 4766	outside
E1	AdverseReaction:T1 Effect:E3
E2	AdverseReaction:T2 Effect:E3
E3	Severity:T3
E4	AdverseReaction:T4 Hypothetical:E5
E5	Factor:T5
E6	AdverseReaction:T1
E7	AdverseReaction:T2
E8	AdverseReaction:T6
E9	AdverseReaction:T7
E10	AdverseReaction:T8
E11	AdverseReaction:T9
E12	AdverseReaction:T10
E13	AdverseReaction:T11
E14	AdverseReaction:T12
E15	AdverseReaction:T13
E16	AdverseReaction:T14
E17	AdverseReaction:T15
E18	AdverseReaction:T16
E19	AdverseReaction:T16 Effect:E20
E20	Severity:T17
E21	AdverseReaction:T18
E22	AdverseReaction:T19
E23	AdverseReaction:T20
E24	AdverseReaction:T21
E25	AdverseReaction:T22
E26	AdverseReaction:T23
E27	AdverseReaction:T24
E28	AdverseReaction:T25
E29	AdverseReaction:T26
E30	AdverseReaction:T27
E33	Severity:T29
E34	Severity:T30
E35	Severity:T31
E36	AdverseReaction:T32
E37	AdverseReaction:T28 Effect:E34 Effect2:E33 Effect3:E35
E39	AdverseReaction:T33
E40	AdverseReaction:T34
E41	AdverseReaction:T35
E42	AdverseReaction:T36
E43	AdverseReaction:T37
E44	AdverseReaction:T38
E46	AdverseReaction:T40
E47	AdverseReaction:T41
E45	AdverseReaction:T39 Effect:E48
E48	Severity:T42
E49	AdverseReaction:T43
E50	AdverseReaction:T44
E51	AdverseReaction:T45
E52	AdverseReaction:T46
E53	AdverseReaction:T47
E54	AdverseReaction:T48
E55	Severity:T49
E56	AdverseReaction:T43 Effect:E55
E57	AdverseReaction:T44 Effect:E55
E58	AdverseReaction:T45 Effect:E55
E59	AdverseReaction:T47 Effect:E55
E60	AdverseReaction:T48 Effect:E55
E61	AdverseReaction:T50 Effect:E63
E62	AdverseReaction:T51 Effect:E63
E63	Severity:T52
E64	AdverseReaction:T53 Hypothetical:E65
E65	Factor:T54
E66	AdverseReaction:T50
E67	AdverseReaction:T51
E68	AdverseReaction:T55
E69	AdverseReaction:T56
E70	AdverseReaction:T55 Effect:E72
E71	AdverseReaction:T56 Effect:E72
E72	Severity:T57
E73	AdverseReaction:T58 Hypothetical:E74
E74	Factor:T59
E75	AdverseReaction:T60 Hypothetical:E74
E76	AdverseReaction:T61 Hypothetical:E77
E77	Factor:T62
E78	AdverseReaction:T63 Effect:E31
E79	AdverseReaction:T64
E81	AdverseReaction:T65 Effect:E82
E82	Severity:T66
E83	AdverseReaction:T67
E84	AdverseReaction:T68
E85	AdverseReaction:T69
E86	AdverseReaction:T70
E31	Severity:T71
E38	AdverseReaction:T73
E32	AdverseReaction:T72 Negated:E80
E80	Negation:T74
A1	CUI E1 C0948245
A2	UMLS-Preferred-Name E1 Cytokine release syndrome
A3	MEDDRA-PT E1 Cytokine release syndrome
A4	MEDDRA-PT-ID E1 10052015
A5	CUI E2 C0948245
A6	UMLS-Preferred-Name E2 Cytokine release syndrome
A7	MEDDRA-PT E2 Cytokine release syndrome
A8	MEDDRA-PT-ID E2 10052015
A9	CUI E4 C1306577
A10	UMLS-Preferred-Name E4 Death (finding)
A11	MEDDRA-PT E4 Death
A12	MEDDRA-PT-ID E4 10011906
A13	CUI E8 C0948715
A14	UMLS-Preferred-Name E8 Infusion related reaction
A15	MEDDRA-PT E8 Infusion related reaction
A16	MEDDRA-PT-ID E8 10051792
A17	CUI E9 C0015967
A18	UMLS-Preferred-Name E9 Fever
A19	MEDDRA-PT E9 Pyrexia
A20	MEDDRA-PT-ID E9 10037660
A21	CUI E10 C0018681
A22	UMLS-Preferred-Name E10 Headache
A23	MEDDRA-PT E10 Headache
A24	MEDDRA-PT-ID E10 10019211
A25	CUI E11 C0027497
A26	UMLS-Preferred-Name E11 Nausea
A27	MEDDRA-PT E11 Nausea
A28	MEDDRA-PT-ID E11 10028813
A29	CUI E12 C0004093
A30	UMLS-Preferred-Name E12 Asthenia
A31	MEDDRA-PT E12 Asthenia
A32	MEDDRA-PT-ID E12 10003549
A33	CUI E13 C0020649
A34	UMLS-Preferred-Name E13 Hypotension
A35	MEDDRA-PT E13 Hypotension
A36	MEDDRA-PT-ID E13 10021097
A37	CUI E14 C0151905
A38	UMLS-Preferred-Name E14 Alanine aminotransferase increased
A39	MEDDRA-PT E14 Alanine aminotransferase increased
A40	MEDDRA-PT-ID E14 10001551
A41	CUI E15 C0151904
A42	UMLS-Preferred-Name E15 Aspartate aminotransferase increased
A43	MEDDRA-PT E15 Aspartate aminotransferase increased
A44	MEDDRA-PT-ID E15 10003481
A45	CUI E16 C0741494
A46	UMLS-Preferred-Name E16 Elevated total bilirubin
A47	MEDDRA-PT E16 Blood bilirubin increased
A48	MEDDRA-PT-ID E16 10005364
A49	LLT E16 Bilirubin total increased
A50	LLT-ID E16 10056806
A51	CUI E17 C1306577
A52	UMLS-Preferred-Name E17 Death (finding)
A53	MEDDRA-PT E17 Death
A54	MEDDRA-PT-ID E17 10011906
A55	CUI E18 C0948245
A56	UMLS-Preferred-Name E18 Cytokine release syndrome
A57	MEDDRA-PT E18 Cytokine release syndrome
A58	MEDDRA-PT-ID E18 10052015
A59	CUI E21 C0012739
A60	UMLS-Preferred-Name E21 Disseminated Intravascular Coagulation
A61	MEDDRA-PT E21 Disseminated intravascular coagulation
A62	MEDDRA-PT-ID E21 10013442
A63	CUI E22 C0012739
A64	UMLS-Preferred-Name E22 Disseminated Intravascular Coagulation
A65	MEDDRA-PT E22 Disseminated intravascular coagulation
A66	MEDDRA-PT-ID E22 10013442
A67	LLT E22 DIC
A68	LLT-ID E22 10012769
A69	CUI E23 C0343084
A70	UMLS-Preferred-Name E23 Capillary Leak Syndrome
A71	MEDDRA-PT E23 Capillary leak syndrome
A72	MEDDRA-PT-ID E23 10007196
A73	CUI E24 C0343084
A74	UMLS-Preferred-Name E24 Capillary Leak Syndrome
A75	MEDDRA-PT E24 Capillary leak syndrome
A76	MEDDRA-PT-ID E24 10007196
A77	CUI E25 C0024291
A78	UMLS-Preferred-Name E25 Lymphohistiocytosis, Hemophagocytic
A79	MEDDRA-PT E25 Histiocytosis haematophagic
A80	MEDDRA-PT-ID E25 10048595
A81	LLT E25 Hemophagocytic lymphohistiocytosis
A82	LLT-ID E25 10071580
A83	CUI E26 C1096155
A84	UMLS-Preferred-Name E26 Macrophage Activation Syndrome
A85	MEDDRA-PT E26 Histiocytosis haematophagic
A86	MEDDRA-PT-ID E26 10048595
A87	LLT E26 Macrophage activation syndrome
A88	LLT-ID E26 10053867
A89	CUI E27 C0024291
A90	UMLS-Preferred-Name E27 Lymphohistiocytosis, Hemophagocytic
A91	MEDDRA-PT E27 Histiocytosis haematophagic
A92	MEDDRA-PT-ID E27 10048595
A93	LLT E27 Hemophagocytic lymphohistiocytosis
A94	LLT-ID E27 10071580
A95	CUI E28 C1096155
A96	UMLS-Preferred-Name E28 Macrophage Activation Syndrome
A97	MEDDRA-PT E28 Histiocytosis haematophagic
A98	MEDDRA-PT-ID E28 10048595
A99	LLT E28 Macrophage activation syndrome
A100	LLT-ID E28 10053867
A101	CUI E29 C0948245
A102	UMLS-Preferred-Name E29 Cytokine release syndrome
A103	MEDDRA-PT E29 Cytokine release syndrome
A104	MEDDRA-PT-ID E29 10052015
A105	CUI E30 C0235032
A106	UMLS-Preferred-Name E30 Neurotoxicity Syndromes
A107	MEDDRA-PT E30 Neurotoxicity
A108	MEDDRA-PT-ID E30 10029350
A109	CUI E37 C0235032
A110	UMLS-Preferred-Name E37 Neurotoxicity Syndromes
A111	MEDDRA-PT E37 Neurotoxicity
A112	MEDDRA-PT-ID E37 10029350
A113	CUI E36 C1306577
A114	UMLS-Preferred-Name E36 Death (finding)
A115	MEDDRA-PT E36 Death
A116	MEDDRA-PT-ID E36 10011906
A117	CUI E39 C0085584
A118	UMLS-Preferred-Name E39 Encephalopathies
A119	MEDDRA-PT E39 Encephalopathy
A120	MEDDRA-PT-ID E39 10014625
A121	CUI E40 C0036572
A122	UMLS-Preferred-Name E40 Seizures
A123	MEDDRA-PT E40 Seizure
A124	MEDDRA-PT-ID E40 10039906
A125	LLT E40 Convulsions
A126	LLT-ID E40 10010914
A127	CUI E41 C0037822
A128	UMLS-Preferred-Name E41 Speech Disorders
A129	MEDDRA-PT E41 Speech disorder
A130	MEDDRA-PT-ID E41 10041466
A131	CUI E42 C0234428
A132	UMLS-Preferred-Name E42 Disturbance of consciousness
A133	MEDDRA-PT E42 Altered state of consciousness
A134	MEDDRA-PT-ID E42 10001854
A135	LLT E42 Consciousness disturbed
A136	LLT-ID E42 10010770
A137	CUI E43 C0009676
A138	UMLS-Preferred-Name E43 Confusion
A139	MEDDRA-PT E43 Confusional state
A140	MEDDRA-PT-ID E43 10010305
A141	LLT E43 Confusion
A142	LLT-ID E43 10010300
A143	CUI E44 C0233407
A144	UMLS-Preferred-Name E44 Disorientation
A145	MEDDRA-PT E44 Disorientation
A146	MEDDRA-PT-ID E44 10013395
A147	CUI E46 C0520966
A148	UMLS-Preferred-Name E46 Abnormal coordination
A149	MEDDRA-PT E46 Coordination abnormal
A150	MEDDRA-PT-ID E46 10010947
A151	LLT E46 Coordination impaired
A152	LLT-ID E46 10010950
A153	CUI E47 C0575090
A154	UMLS-Preferred-Name E47 Equilibration disorder
A155	MEDDRA-PT E47 Balance disorder
A156	MEDDRA-PT-ID E47 10049848
A157	CUI E45 C3714514
A158	UMLS-Preferred-Name E45 Infection
A159	MEDDRA-PT E45 Infection
A160	MEDDRA-PT-ID E45 10021789
A161	CUI E49 C0243026
A162	UMLS-Preferred-Name E49 Sepsis
A163	MEDDRA-PT E49 Sepsis
A164	MEDDRA-PT-ID E49 10040047
A165	CUI E50 C0032285
A166	UMLS-Preferred-Name E50 Pneumonia
A167	MEDDRA-PT E50 Pneumonia
A168	MEDDRA-PT-ID E50 10035664
A169	CUI E51 C0004610
A170	UMLS-Preferred-Name E51 Bacteremia
A171	MEDDRA-PT E51 Bacteraemia
A172	MEDDRA-PT-ID E51 10003997
A173	LLT E51 Bacteremia
A174	LLT-ID E51 10003999
A175	CUI E52 C1306577
A176	UMLS-Preferred-Name E52 Death (finding)
A177	MEDDRA-PT E52 Death
A178	MEDDRA-PT-ID E52 10011906
A179	CUI E53 C0029118
A180	UMLS-Preferred-Name E53 Opportunistic Infections
A181	MEDDRA-PT E53 Opportunistic infection
A182	MEDDRA-PT-ID E53 10030901
A183	CUI E54 C1112210
A184	UMLS-Preferred-Name E54 Catheter site infection
A185	MEDDRA-PT E54 Catheter site infection
A186	MEDDRA-PT-ID E54 10056520
A187	CUI E61 C0041364
A188	UMLS-Preferred-Name E61 Tumor Lysis Syndrome
A189	MEDDRA-PT E61 Tumour lysis syndrome
A190	MEDDRA-PT-ID E61 10045170
A191	LLT E61 Tumor lysis syndrome
A192	LLT-ID E61 10045152
A193	CUI E62 C0041364
A194	UMLS-Preferred-Name E62 Tumor Lysis Syndrome
A195	MEDDRA-PT E62 Tumour lysis syndrome
A196	MEDDRA-PT-ID E62 10045170
A197	LLT E62 Tumor lysis syndrome
A198	LLT-ID E62 10045152
A199	CUI E64 C1306577
A200	UMLS-Preferred-Name E64 Death (finding)
A201	MEDDRA-PT E64 Death
A202	MEDDRA-PT-ID E64 10011906
A203	CUI E68 C0027947
A204	UMLS-Preferred-Name E68 Neutropenia
A205	MEDDRA-PT E68 Neutropenia
A206	MEDDRA-PT-ID E68 10029354
A207	CUI E69 C0746883
A208	UMLS-Preferred-Name E69 Febrile Neutropenia
A209	MEDDRA-PT E69 Febrile neutropenia
A210	MEDDRA-PT-ID E69 10016288
A211	CUI E73 C0235030
A212	UMLS-Preferred-Name E73 Neurologic reaction
A213	MEDDRA-PT E73 Neurological symptom
A214	MEDDRA-PT-ID E73 10060860
A215	LLT E73 Neurologic reaction
A216	LLT-ID E73 10029290
A217	CUI E75 C0036572
A218	UMLS-Preferred-Name E75 Seizures
A219	MEDDRA-PT E75 Seizure
A220	MEDDRA-PT-ID E75 10039906
A221	LLT E75 Seizures
A222	LLT-ID E75 10039910
A223	CUI E76 C0041657
A224	UMLS-Preferred-Name E76 Unconscious State
A225	MEDDRA-PT E76 Loss of consciousness
A226	MEDDRA-PT-ID E76 10024855
A227	CUI E78 C0235996
A228	UMLS-Preferred-Name E78 Elevated liver enzymes
A229	MEDDRA-PT E78 Hepatic enzyme increased
A230	MEDDRA-PT-ID E78 10060795
A231	LLT E78 Elevated liver enzymes
A232	LLT-ID E78 10014481
A233	CUI E79 C0948245
A234	UMLS-Preferred-Name E79 Cytokine release syndrome
A235	MEDDRA-PT E79 Cytokine release syndrome
A236	MEDDRA-PT-ID E79 10052015
A237	CUI E81 C0235996
A238	UMLS-Preferred-Name E81 Elevated liver enzymes
A239	MEDDRA-PT E81 Hepatic enzyme increased
A240	MEDDRA-PT-ID E81 10060795
A241	LLT E81 Elevated liver enzymes
A242	LLT-ID E81 10014481
A243	CUI E83 C0270612
A244	UMLS-Preferred-Name E83 Leukoencephalopathies
A245	MEDDRA-PT E83 Leukoencephalopathy
A246	MEDDRA-PT-ID E83 10024382
A247	CUI E84 C3714514
A248	UMLS-Preferred-Name E84 Infection
A249	MEDDRA-PT E84 Infection
A250	MEDDRA-PT-ID E84 10021789
A251	CUI E85 C0877256
A252	UMLS-Preferred-Name E85 Impaired driving ability
A253	MEDDRA-PT E85 Impaired driving ability
A254	MEDDRA-PT-ID E85 10049564
A255	LLT E85 Driving ability disturbed
A256	LLT-ID E85 10050503
A257	flag E86 unmapped
A258	CUI E38 C0948245
A259	UMLS-Preferred-Name E38 Cytokine release syndrome
A260	MEDDRA-PT E38 Cytokine release syndrome
A261	MEDDRA-PT-ID E38 10052015
A262	CUI E32 C0948245
A263	UMLS-Preferred-Name E32 Cytokine release syndrome
A264	MEDDRA-PT E32 Cytokine release syndrome
A265	MEDDRA-PT-ID E32 10052015
